Paul McDonald

speaker

78 appearances 1 recordings 1 series first heard Jun 2026 last heard 30 Jun

Paul McDonald’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.

Appearances

newest first · ▶ plays the moment

FEAR & GREED | Business News · Q+A: The next medical breakthrough Australia wants to own · 30 Jun 2026 podcast

There are other types as well, but they're the two that are used commercially.

The siRNAs have been used in major muscular disorders and neuromuscular disorders for quite some time.

And there's two single billion dollar products in the market treating those disorders already.

So now we're quite familiar for the last few decades

to be developing those type of drugs, but it's definitely had a real substantial push since the COVID pandemic.

Yeah, so the mRNA vaccines were developed for respiratory response.

And as I explained, the

those mRNA sequences were used to code the spike antigen of the virus.

So to simulate an interaction with COVID by the body, so it would create and build its own immune system.

So then when you come in contact with COVID, your immune system, your secondary immune system's been primed with the right antibodies to attack those antigens.

So that's how the mRNA vaccine

But where it's going is respiratory diseases.

We're looking right now at foot and mouth disease, lumpy skin disease.

There's known technologies now being developed for those biosecurity.

If those diseases come into Australia, it'll completely disrupt Australia's livestock industry to the effect of billions of dollars.

So there are...

opportunities there being developed.

There's opportunities in cancer.

As I said, you think those two modes, one to design something that will build an enzyme or a protein to have a specific action or one to switch one off.

So that proves really nicely for cancer.

Showing 21–40 of 78 · page 2 of 4